Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06610617 · ClinicalTrials.gov registry record · NA
Neuromodulation of Central Sensory Integration to Improve Postural Control
A NA study of Quality of Life and Survivorship, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06610617: Completed NA study of Quality of Life and Survivorship, sponsored by University of Pittsburgh.
NCT06610617 is a NA study of Quality of Life and Survivorship that has completed, run by University of Pittsburgh. The registered enrollment target is 48 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06610617, a NA study of Quality of Life and Survivorship, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to evaluate if neuromodulation of the PFC can acutely improve sensory integration for balance performance in OTTBCS.
Primary Outcome
The primary outcome measure of Aim 2 will be the change in composite equilibrium score from before and immediately after a single exposure of tDCS or sham stimulation. Briefly, equilibrium score is assessment of postural sway, which can range from 0 to 100, where a lower score indicates more sway and a zero indicates a fall.
Conditions Studied
Interventions
- DEVICE Sham tDCS
- DEVICE transcranial direct current stimulation (tDCS)
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-10-14 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT06610617 record still lists
NCT06610617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 2 interventions - of which Sham tDCS is the first listed.
NCT06610617 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06610617 about?
NCT06610617 is a clinical study titled "Neuromodulation of Central Sensory Integration to Improve Postural Control". The objective is to evaluate if neuromodulation of the PFC can acutely improve sensory integration for balance performance in OTTBCS.
What is the current status of trial NCT06610617?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2024-10-14. Estimated completion is 2025-07-31.
What conditions does trial NCT06610617 study?
This clinical trial studies the following conditions: Quality of Life, Survivorship, Cognitive Deficits, Mild.
What interventions are being tested in trial NCT06610617?
The interventions under investigation include: Sham tDCS (DEVICE), transcranial direct current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT06610617?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06610617 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06610617's enrollment target sits among peer trials
48 76th of 107 higher than 31 of 107 other Quality of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI